Angola vs Brazil: Tuberculosis patients who tested positive for HIV
Angola
5,619 patients
in 2021
Brazil
6,870 patients
in 2021
Angola rank
15th
Brazil rank
13th
Tuberculosis patients who tested positive for HIV over time
- Angola
- Brazil
How they compare
Brazil currently reports 6,870 patients against 5,619 patients in Angola, a difference of 1,251 patients.
That makes Brazil's figure about 1.2 times Angola's.
Across all 14 years both countries report, Brazil has been ahead every year.
Angola ranks 15th and Brazil ranks 13th of 201 countries.
Brazil has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Angola | Brazil | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 378 patients | 8,250 patients | 7,872 patients | Brazil |
| 2010s | 2,602 patients | 8,556 patients | 5,954 patients | Brazil |
| 2020s | 5,432 patients | 6,738 patients | 1,306 patients | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients who tested positive for hiv, Angola or Brazil?
- Brazil, at 6,870 patients against 5,619 patients in Angola as of 2021.
- What is the difference in tuberculosis patients who tested positive for hiv between Angola and Brazil?
- 1,251 patients, with Brazil ahead.
- How many years of comparable data are there for Angola and Brazil?
- 14 years are reported by both, from 2007 to 2021.
- How do Angola and Brazil rank globally for tuberculosis patients who tested positive for hiv?
- Angola ranks 15th and Brazil ranks 13th of 201 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients who tested positive for HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of tuberculosis (new and relapsed) patients that tested positive for HIV.